- Investing Ideas
- U.S. Pharmaceuticals & Biotech Nano Cap Stocks
U.S. Pharmaceuticals & Biotech Nano Cap Stocks
Results
19
Stocks with a market cap under US$50M.
19 companies
aTyr Pharma
Market Cap: US$49.4m
A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.
ATYR
US$0.53
7D
-1.4%
1Y
-89.2%
Grace Therapeutics
Market Cap: US$44.8m
Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
GRCE
US$2.20
7D
4.8%
1Y
-32.7%
biote
Market Cap: US$44.1m
Operates in practice-building business within the hormone optimization space.
BTMD
US$1.36
7D
-4.2%
1Y
-54.2%
Bioqual
Market Cap: US$29.1m
Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.
BIOQ
US$32.50
7D
0%
1Y
n/a
Dyadic International
Market Cap: US$27.8m
A biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States.
DYAI
US$0.74
7D
-16.0%
1Y
-8.8%
Jasper Therapeutics
Market Cap: US$24.9m
A clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States.
JSPR
US$0.75
7D
-9.4%
1Y
-73.8%
BioXcel Therapeutics
Market Cap: US$24.8m
Together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.
BTAI
US$0.83
7D
-21.9%
1Y
-83.6%
Earth Science Tech
Market Cap: US$24.4m
Together with its subsidies, focuses on health and wellness industry.
ETST
US$0.11
7D
8.1%
1Y
-44.4%
TherapeuticsMD
Market Cap: US$23.3m
Operates as a pharmaceutical royalty company in the United States and internationally.
TXMD
US$2.03
7D
-2.4%
1Y
82.9%
Cellectar Biosciences
Market Cap: US$20.7m
A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.
CLRB
US$2.62
7D
0.8%
1Y
-40.6%
Biofrontera
Market Cap: US$18.4m
A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
BFRI
US$1.42
7D
13.6%
1Y
61.3%
Bio Essence
Market Cap: US$13.5m
Engages in manufacturing and distributing health supplement products.
BIOE
US$0.25
7D
0%
1Y
108.5%
Pharma-Bio Serv
Market Cap: US$12.4m
Operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.
PBSV
US$0.42
7D
-21.7%
1Y
-29.6%
PDS Biotechnology
Market Cap: US$11.6m
A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States.
PDSB
US$0.20
7D
-17.1%
1Y
-82.8%
CordovaCann
Market Cap: US$4.4m
Engages in the provision of services and investment capital to the processing, production, and retail vertical markets of the cannabis industry in Canada and United States.
LVRL.F
US$0.04
7D
0%
1Y
-27.6%
International Stem Cell
Market Cap: US$3.9m
A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.
ISCO
US$0.51
7D
57.0%
1Y
216.1%
Emmaus Life Sciences
Market Cap: US$772.1k
A commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally.
EMMA
US$0.013
7D
3.2%
1Y
3.2%
Ayurcann Holdings
Market Cap: US$58.4k
Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.
AYUR.F
US$0.0003
7D
0%
1Y
-98.3%
Sunset Island Group
Market Cap: US$34.4k
Through its subsidiary, VBF Brands, grows, cultivates, manufactures, and distributes cannabis in the United States.
SIGO
US$0.0001
7D
0%
1Y
n/a